Cargando…

Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study

OBJECTIVE: Multiple System Atrophy (MSA) and progressive supranuclear palsy (PSP) are rapidly progressive forms of degenerative Parkinsonism. The difficulties of diagnosing MSA and PSP in their early stages may lead to delayed referral to appropriate specialists and distress to patients, as well as...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiblin, Louise, Durcan, Rory, Galna, Brook, Lee, Mark, Burn, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Movement Disorder Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763719/
https://www.ncbi.nlm.nih.gov/pubmed/31390854
http://dx.doi.org/10.14802/jmd.19015
_version_ 1783454258147885056
author Wiblin, Louise
Durcan, Rory
Galna, Brook
Lee, Mark
Burn, David
author_facet Wiblin, Louise
Durcan, Rory
Galna, Brook
Lee, Mark
Burn, David
author_sort Wiblin, Louise
collection PubMed
description OBJECTIVE: Multiple System Atrophy (MSA) and progressive supranuclear palsy (PSP) are rapidly progressive forms of degenerative Parkinsonism. The difficulties of diagnosing MSA and PSP in their early stages may lead to delayed referral to appropriate specialists and distress to patients, as well as delaying symptomatic treatment and participation in clinical trials. This work aimed to describe the symptoms that patients with MSA and PSP developed and plot their emergence relative to final diagnosis using a median onset in months. METHODS: Forty-seven patients from the United Kingdom with MSA or PSP diagnosed by a movement disorder specialist were interviewed with carers or relatives to establish milestone onset. This was corroborated using clinical notes and letters. RESULTS: In the MSA cohort (n = 23), autonomic symptoms (median 5.5 months before diagnosis) and falls (median 1 month before diagnosis) were the two clinical milestones which occurred before diagnosis. In the PSP cohort (n = 24), falling was the only milestone which occurred before diagnosis (median of 18.5 months). CONCLUSION: This Study Shows That Psp Patients Experience Falling More Than A Year And A Half An Average Before Receiving A Diagnosis And Although Msa Patients Also Tended To Fall, This Was Much Closer To The Time Of Diagnosis. Further Work With Larger Cohorts May Illustrate Whether These Preliminary Findings Can Be Generalised To Guide Diagnosis And Management.
format Online
Article
Text
id pubmed-6763719
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Korean Movement Disorder Society
record_format MEDLINE/PubMed
spelling pubmed-67637192019-10-08 Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study Wiblin, Louise Durcan, Rory Galna, Brook Lee, Mark Burn, David J Mov Disord Original Article OBJECTIVE: Multiple System Atrophy (MSA) and progressive supranuclear palsy (PSP) are rapidly progressive forms of degenerative Parkinsonism. The difficulties of diagnosing MSA and PSP in their early stages may lead to delayed referral to appropriate specialists and distress to patients, as well as delaying symptomatic treatment and participation in clinical trials. This work aimed to describe the symptoms that patients with MSA and PSP developed and plot their emergence relative to final diagnosis using a median onset in months. METHODS: Forty-seven patients from the United Kingdom with MSA or PSP diagnosed by a movement disorder specialist were interviewed with carers or relatives to establish milestone onset. This was corroborated using clinical notes and letters. RESULTS: In the MSA cohort (n = 23), autonomic symptoms (median 5.5 months before diagnosis) and falls (median 1 month before diagnosis) were the two clinical milestones which occurred before diagnosis. In the PSP cohort (n = 24), falling was the only milestone which occurred before diagnosis (median of 18.5 months). CONCLUSION: This Study Shows That Psp Patients Experience Falling More Than A Year And A Half An Average Before Receiving A Diagnosis And Although Msa Patients Also Tended To Fall, This Was Much Closer To The Time Of Diagnosis. Further Work With Larger Cohorts May Illustrate Whether These Preliminary Findings Can Be Generalised To Guide Diagnosis And Management. The Korean Movement Disorder Society 2019-09 2019-08-09 /pmc/articles/PMC6763719/ /pubmed/31390854 http://dx.doi.org/10.14802/jmd.19015 Text en Copyright © 2019 The Korean Movement Disorder Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Wiblin, Louise
Durcan, Rory
Galna, Brook
Lee, Mark
Burn, David
Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study
title Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study
title_full Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study
title_fullStr Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study
title_full_unstemmed Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study
title_short Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study
title_sort clinical milestones preceding the diagnosis of multiple system atrophy and progressive supranuclear palsy: a retrospective cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763719/
https://www.ncbi.nlm.nih.gov/pubmed/31390854
http://dx.doi.org/10.14802/jmd.19015
work_keys_str_mv AT wiblinlouise clinicalmilestonesprecedingthediagnosisofmultiplesystematrophyandprogressivesupranuclearpalsyaretrospectivecohortstudy
AT durcanrory clinicalmilestonesprecedingthediagnosisofmultiplesystematrophyandprogressivesupranuclearpalsyaretrospectivecohortstudy
AT galnabrook clinicalmilestonesprecedingthediagnosisofmultiplesystematrophyandprogressivesupranuclearpalsyaretrospectivecohortstudy
AT leemark clinicalmilestonesprecedingthediagnosisofmultiplesystematrophyandprogressivesupranuclearpalsyaretrospectivecohortstudy
AT burndavid clinicalmilestonesprecedingthediagnosisofmultiplesystematrophyandprogressivesupranuclearpalsyaretrospectivecohortstudy